Want to see HK:1143 full AI Analyst Report?
1143 Stock Chart & Stats
HK$0.38
<HK$0.01(1.61%)
At close: 4:00 PM EST
HK$0.38
<HK$0.01(1.61%)
Day’s Range― - ―
52-Week RangeHK$0.28 - HK$0.53
Previous CloseN/A
Volume324.00K
Average Volume (3M)1.09M
Market Cap
HK$99.81M
Enterprise Value-HK$137.89M
Total Cash (Recent Filing)HK$246.90M
Total Debt (Recent Filing)HK$49.27M
Price to Earnings (P/E)―
Beta0.46
Next Earnings
Aug 27, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.20
Shares Outstanding224,289,180
10 Day Avg. Volume1,292,540
30 Day Avg. Volume1,091,788
Financial Highlights & Ratios
PEG Ratio<0.01
Price to Book (P/B)0.17
Price to Sales (P/S)0.24
P/FCF Ratio-4.54
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Bulls Say, Bears Say
Bulls Say
Low Leverage / Balance-sheet FlexibilityA low debt-to-equity ratio provides durable financial flexibility: the company can absorb operating shortfalls, access incremental financing on better terms, and avoid forced asset sales. This structural strength gives management time to execute a turnaround without immediate balance-sheet distress.
Gross Margin ImprovementThe recovery in gross margin suggests improved product mix, pricing power, or cost control that can sustain better unit profitability even before revenue growth returns. If sustained, higher gross margins materially lower the revenue threshold needed for operating break-even and support margin recovery.
Proven Historical Cash-generation AbilityPast ability to generate meaningful operating and free cash flow demonstrates the business can be cash-accretive under the right conditions. That track record indicates operational levers exist to restore cash conversion, making a durable recovery feasible if top-line pressures are addressed.
Bears Say
Multi-year Revenue DeclineSustained top-line contraction erodes scale economics, weakens bargaining power with suppliers and customers, and reduces capacity to cover fixed costs. Over months, continued revenue decline undermines the case for durable margin recovery and raises execution risk for any turnaround plans.
Return To Meaningful LossesA return to meaningful net and operating losses signals structural profitability issues. Persistent negative margins deplete equity, constrain reinvestment in product and distribution, and increase the likelihood management must undertake disruptive restructuring or curtail strategic initiatives.
Persistent Negative Operating & Free Cash FlowSustained negative operating and free cash flow create ongoing liquidity pressure, forcing reliance on financing or asset sales. This limits the company's ability to fund capex, R&D, or working-capital needs organically and increases long-term execution and solvency risk if cash burn continues.
Link-Asia International Medtech Group Ltd. News
1143 FAQ
What was Link-Asia International Medtech Group Ltd.’s price range in the past 12 months?
Link-Asia International Medtech Group Ltd. lowest stock price was HK$0.28 and its highest was HK$0.53 in the past 12 months.
What is Link-Asia International Medtech Group Ltd.’s market cap?
Link-Asia International Medtech Group Ltd.’s market cap is HK$99.81M.
When is Link-Asia International Medtech Group Ltd.’s upcoming earnings report date?
Link-Asia International Medtech Group Ltd.’s upcoming earnings report date is Aug 27, 2026 which is in 17 days.
How were Link-Asia International Medtech Group Ltd.’s earnings last quarter?
Link-Asia International Medtech Group Ltd. released its earnings results on Mar 31, 2026. The company reported -HK$0.126 earnings per share for the quarter, missing the consensus estimate of N/A by -HK$0.126.
Is Link-Asia International Medtech Group Ltd. overvalued?
According to Wall Street analysts Link-Asia International Medtech Group Ltd.’s price is currently Overvalued.
Does Link-Asia International Medtech Group Ltd. pay dividends?
Link-Asia International Medtech Group Ltd. pays a Notavailable dividend of HK$0.293 which represents an annual dividend yield of N/A. See more information on Link-Asia International Medtech Group Ltd. dividends here
What is Link-Asia International Medtech Group Ltd.’s EPS estimate?
Link-Asia International Medtech Group Ltd.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Link-Asia International Medtech Group Ltd. have?
Link-Asia International Medtech Group Ltd. has 224,289,180 shares outstanding.
What happened to Link-Asia International Medtech Group Ltd.’s price movement after its last earnings report?
Link-Asia International Medtech Group Ltd. reported an EPS of -HK$0.126 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went up 2.564%.
Which hedge fund is a major shareholder of Link-Asia International Medtech Group Ltd.?
Currently, no hedge funds are holding shares in HK:1143
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Link-Asia International Medtech Group Ltd. Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Technicals
SMA
Positive
20 days / 200 days
Momentum
34.37%
12-Months-Change
Fundamentals
Return on Equity
―
Trailing 12-Months
Asset Growth
-8.68%
Trailing 12-Months
Company Description
Link-Asia International Medtech Group Ltd.
Headquartered in Tsim Sha Tsui, Hong Kong, this investment holding company was founded in 1992 as Link-Asia International Co. Ltd. and rebranded to Link-Asia International MedTech Group Limited in December 2020. It primarily offers electronic manufacturing services (EMS) for a diverse range of products, including telecommunications, security, automotive electronics, home appliances, and other consumer and industrial electronic devices. The company's operations are structured across four key divisions: EMS, the distribution of communication products, investments in securities and other assets, and real estate supply chain services. In addition to its core EMS business, the firm is involved in trading personal care products, business telephone systems, and telecommunication products. It also manufactures and sells telecommunications and consumable electronic items, sells audio equipment, and provides consultancy services. A notable aspect of its portfolio includes pre-pregnancy care and assisted reproductive services. Furthermore, it offers equity investment, property agency, and real estate advisory and purchasing services. The company boasts a significant international presence, operating in the People's Republic of China, the United States, Switzerland, France, Poland, the United Kingdom, Belgium, Russia, Thailand, Malaysia, Brazil, and other global markets.